NEW YORK (GenomeWeb) – NanoString Technologies said today that it has made an agreement to sell 3 million shares of its common stock at $16.75 per share with RW Baird as the sole underwriter in a public offering pursuant to NanoString's existing shelf registration statement filed in 2014.

The firm has also granted Baird a 30-day option to purchase up to an additional 450,000 shares of common stock.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.